2282
S. S. Chimni et al. / Tetrahedron: Asymmetry 19 (2008) 2276–2284
J = 6 Hz, CH (anti)), 6.96–7.02 (t, 1H, J = 9 Hz, ArH), 7.12–7.28 (m,
2H, ArH), 7.43–7.48 (t, 1H, J = 7.5 Hz, ArH).
18.0, 18.2, 20.8, 21, 26.5, 30.9, 31.3, 32.6, 32.9, 33.4, 34.6, 35.4,
35.9, 38, 38.4, 40.6, 41.5, 52, 53, 53.3, 55.6, 69.7, 70.2, 73.8,
123.2, 123.3, 123.4, 126.4, 127.6, 127.7, 146.8, 147.4, 148.5,
149.2, 213.9, 214.6.
4.3.11. 2-[10-Hydroxy-10-(200-chlorophenyl)methyl] cyclohexan-
1-one16d 4k
4.3.16. 2-[10-Hydroxy-10-(200-nitrophenyl)methyl]-4-
methylcyclohexan-1-one 616b
Yield: 69%; anti/syn = 98:2; enantiomeric excess: 91% deter-
mined by HPLC (Diacel Chiralpak AD-H; hexane/i-PrOH 90:10; flow
rate 0.3 mL/min; k = 225 nm; tR (syn, major) = 11.08 min, tR (syn,
minor) = 12.10, (anti, major) = 19.35 min, tR (anti, minor) = 21.89
min; 1H NMR (CDCl3, 300 MHz): d 1.55–1.82 (m, 5H, CH2), 2.07–
2.11 (m, 1H, CH2), 2.27–2.48 (m, 2H, CH2), 2.59–2.62 (m, 1H, CH),
3.96 (br s, 1H, OH), 5.29–5.31 (d, 1H, J = 6 Hz, CH (anti)), 5.67 (s,
1H, CH (syn)), 7.17–7.32 (m, 3H, ArH), 7.51–7.54 (d, 1H, ArH). 13C
NMR (CDCl3, 300 MHz): d 24.7, 25.8, 27.8, 42.5, 53.5, 67.6, 126.5,
128.1, 128.4, 129.1, 130.7, 138.5, 214.7.
Yield: 85%, enantiomeric excess: 95% of major diastereomer
determined by HPLC (Diacel Chiralpak AD-H; hexane/i-PrOH
80:20; flow rate 0.8 mL/min; k = 225 nm; tR (minor) = 9.41 min, tR
(major) = 9.98 min; 1H NMR (CDCl3, 300 MHz): d 0.81–1.10 (m
3H, CH3), 1.35–1.60 (m, 1H, CH), 1.67–2.01 (m, 3H, CH2), 2.05–
2.25 (m, 1H, CH2), 2.27–2.65 (m, 2H, CH2), 2.80–3.10 (m, 1H, CH),
5.42–5.44 (d, 0.9H, J = 6 Hz, CHOH), 5.94 (bd, 0.1H, J = 2.7 Hz,
CHOH), 7.40–7.46 (m, 1H, ArH), 7.60–7.66 (m, 1H, ArH) 7.72–
7.76 (m, 1H, ArH) 7.82–7.85 (m, 1H, ArH); 13C NMR (CDCl3,
300 MHz): d 20.2, 22.1, 23, 26.6, 29, 30.9, 34.5, 38.2, 38.4, 38.8,
40.6, 54.9, 55.9, 64.9, 69.9,74, 120.4, 121.4, 122, 122.7, 126.7,
127.3, 128.3, 129.1, 129.3, 131.5, 132.6, 143.5, 145.2, 148.1,
219.6, 222.2.
4.3.12. 2-[10-Hydroxy-10-(200-bromophenyl)methyl] cyclohexan-
1-one 4l
Yield: 73%; anti/syn = 86:14; enantiomeric excess: 82%
determined by HPLC (Diacel Chiralpak AD-H, hexane/i-PrOH
90:10; flow rate 0.3 mL/min; k = 225 nm; tR (anti, major) = 37.2
min, tR (anti, minor) = 42.9 min; 1H NMR (CDCl3, 300 MHz): d
1.25–1.86 (m, 5H, CH2), 2.07–2.11 (m, 1H, CH2), 2.27–2.48 (m,
2H, CH2), 2.60–2.69 (m, 1H, CH), 3.98 (br s, 1H, OH), 5.25–5.28
(d, 1H, J = 9 Hz, CH (anti)), 7.09–7.17 (m, 1H, ArH), 7.25–7.35 (m,
1H, ArH), 7.48–7.52 (m, 2H, ArH); 13C NMR (CDCl3, 300 MHz): d
24.8, 27.7, 30.4, 42.6, 57.5, 72.7, 123.2, 127.7, 128.4, 129, 132.4,
140.6, 215.
4.3.17. 2-[10-Hydroxy-10-(400-chlorophenyl)methyl]-4-
methylcyclohexan-1-one 716b
Yield: 80%, enantiomeric excess 97% of major diastereomer
determined by HPLC (Diacel Chiralpak AS-H; hexane/i-PrOH
90:10; flow rate 0.8 mL/min; k = 225 nm; tR (anti, major) = 15.78
min, tR (anti, minor) = 25.20 min; 1H NMR (mixture of isomers)
(CDCl3, 300 MHz): d 0.92–1.04 (m, 3H, CH3), 1.25–1.50 (m, 2H,
CH and CH2), 1.71–1.76 (m, 1H, CH2), 1.89–2.06 (m, 2H, CH2),
2.25–2.57 (m, 2H, CH2), 2.65–2.78 (m, 1H, CH), 3.32 (br, 1H, OH),
4.72–4.75 (d, 0.8H, J = 9 Hz, CHOH), 5.31–5.34 (m, 0.2H, CHOH),
7.21–7.36 (m, 4H, ArH); 13C NMR (of three isomers) (CDCl3,
300 MHz): d 14.0, 18.5, 21.2, 26.6, 29.6, 31.5, 33.2, 33.6, 35.6,
36.1, 38.1, 41.7, 53.4, 55.9, 69.8, 74.1, 127.1, 128.2, 128.6, 129.4,
130.8, 133.6, 139.6, 215.2.
4.3.13. 2-[10-Hydroxy-10-phenylmethyl]cyclohexan-1-one16a 4m
Yield: 62%; anti/syn = 87:13; enantiomeric excess: 82% deter-
mined by HPLC (Diacel Chiralpak AD-H; hexane/i-PrOH 95:5; flow
rate 1 mL/min; k = 211 nm; tR (syn, major) = 12.1 min, tR (syn, min-
or) = 13.4, tR (anti, major) = 14.6 min, tR (anti, minor) = 16 min; 1H
NMR (CDCl3, 300 MHz): d 1.25–1.86 (m, 5H, CH2), 1.98–2.09 (m,
1H, CH2), 2.29–2.56 (m, 3H, CH2 and CH), 2.96 (br s, 1H, OH
(syn)), 3.89 (br s, 1H, OH (anti)), 4.74–4.77 (d, 1H, J = 9 Hz, CH
(anti)), 5.36 (s, 1H, CH (syn)), 7.21–7.29 (m, 5H, ArH).
4.3.18. 7-[10-Hydroxy-10-(400-nitrophenyl)methyl]-1,4-dioxa-
spiro-[4.5]decan-8-one 816a
4.3.14. 2-[10-Hydroxy-10-(naphthalene-2-yl)methyl]
cyclohexan-1-one16e 4n
Yield: 70%, anti/syn = 85:15; enantiomeric excess: 91% of anti
diastereomer determined by HPLC (Diacel Chiralpak AS-H, hex-
ane/i-PrOH 70:30, flow rate 1.0 mL/min; k = 254 nm; tR (anti, min-
or) = 10.61 min, tR (anti, major) = 14.99 min; 1H NMR (CDCl3,
300 MHz): d 1.45–1.55 (m, 1H, CH2), 1.90–2.13 (m, 3H, CH2),
2.41–2.51 (m, 1H, CH2), 2.64–2.81 (m, 1H, CH2), 2.93–3.03 (m,
1H, CH), 3.09 (d, 1H, J = 6 Hz, OH (syn)), 3.84–3.96 (m, 4H, CH2),
4.04–4.05 (d, 1H, J = 3 Hz, OH (anti)), 4.92 (d, 1H, J = 7.8 Hz, CHOH
(anti)), 5.52 (m, 1H, CHOH (syn)), 7.46–7.51 (m, 2H, ArH), 8.19–8.22
(m, 2H, ArH); 13C NMR (CDCl3, 300 MHz): d 33.0, 34.2, 37.7, 38.4,
38.7, 52.9, 64.5, 64.6, 64.7, 69.5, 76.5, 106.7, 107.2, 123.5, 123.6,
126.4, 127.8, 148.5.
Yield: 35%; anti/syn = 93:7; enantiomeric excess: 79% deter-
mined by HPLC (Diacel Chiralpak AS-H; hexane/i-PrOH 90:10; flow
rate 0.5 mL/min; k = 225 nm; tR (syn, major) = 19.13 min, tR (syn,
minor) = 21.41, tR (anti, major) = 25.0 min, tR (anti, minor) = 27.98 -
min; 1H NMR (CDCl3, 300 MHz)
d 1.40–1.90 (m, 5H, CH2),
2.07–2.26 (m, 1H, CH2), 2.28–2.58 (m, 2H, CH2), 2.62–2.79 (m,
1H, CH), 3.20 (br s, 1H, OH (syn)), 4.06 (br s, 1H, OH (anti)), 4.94–
4.97 (d, 1H, J = 9 Hz, CHOH (anti)), 5.55 (s, 1H, CHOH (syn)), 7.36–
7.49 (m, 3H, ArH), 7.74–7.84 (m, 4H, ArH); 13C NMR (CDCl3,
300 MHz): d 24.5, 24.7, 25.9, 27.6, 27.8, 30.8, 42.5, 56.9, 57.3,
70.6, 74.7, 123.8, 124.4, 124.5, 125.5, 125.8, 125.9, 126, 126.1,
127.5, 127.6, 127.7, 127.8, 128.1, 132.5, 133, 133.1, 138.2, 138.8,
214.7, 215.4.
4.3.19. 2-[10-Hydroxy-10-(400-nitrophenyl)methyl]-4-tert-
butylcyclohexan-1-one 916c
Yield: 90%, enantiomeric excess: 92% of major diastereomer
determined by HPLC (Diacel Chiralpak OD-H; hexane/i-PrOH
92:8; flow rate 0.5 mL/min; k = 280 nm; tR (major) = 21.76 min, tR
(minor) = 24.70 min; 1H NMR (mixture of isomers) (CDCl3,
300 MHz): d 0.78, 0.81, 0.82 (3s, 9H, CH3), 1.40–1.67 (m, 4H, CH
and CH2), 2.09–2.15 (m, 1H, CH2), 2.40–2.52 (m, 2H, CH2), 2.65–
2.67 (m, 1H, CH), 3.14–3.15 (br s, 1H, OH), 4.95–4.98 (d, 0.3H,
J = 9 Hz, CHOH), 5.48 (s, 0.7H, CHOH), 7.47–7.55 (m, 2H, ArH),
8.19–8.25 (m, 2H, ArH); 13C NMR (mixture of isomers) (CDCl3,
300 MHz): d 26.7, 27.4, 27.5, 28.4, 28.5, 31.7, 32.4, 32.5, 41.8, 42,
46.4, 46.5, 55.8, 56, 70.1, 74.1, 123.4, 123.5, 126.5, 127.7, 147,
147.4, 148.4, 149.1.
4.3.15. 2-[10-Hydroxy-10-(400-nitrophenyl)methyl]-4-
methylcyclohexan-1-one 516b
Yield: 88%, enantiomeric excess: 95% of major diastereomer
determined by HPLC (Diacel Chiralpak AS-H; hexane/i-PrOH
70:30; flow rate 0.8 mL/min; k = 254 nm; tR (major) = 13.23 min,
tR (minor) = 18.45 min; 1H NMR (mixture of isomers) (CDCl3,
300 MHz): d 0.90–0.94 (m, 1H, CH3), 1.04–1.07 (m, 2H, CH3)
1.30–1.60 (m, 2H, CH2), 1.77–2.11 (m, 3H, CH and CH2), 2.32–
2.79 (m, 3H, CH2), 4.00 (br s, 1H, OH), 4.93 (d, 0.7H, J = 8.7 Hz,
CHOH), 5.47 (s, 0.3H, CHOH), 7.47–7.52 (m, 2H, ArH), 8.19–8.22
(m, 2H, ArH); 13C NMR (mixture of isomers) (CDCl3, 300 MHz): d